Company Announcement COPENHAGEN, Denmark; June 2, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restricted Stock Unit program.

Phase 3 IFx-Hu2.0 trial as an adjunctive therapy with Keytruda® (pembrolizumab) in checkpoint inhibitor (CPI)-naïve patients with advanced or metastatic Merkel cell carcinoma (MCC) detailed in Trial in Progress Poster at ASCO Phase 3 trial of IFx-Hu2.0 to be conducted under Accelerated Approval Pathway and Special Protocol Assessment (SPA) agreement with U.S. Food and Drug Administration (FDA) TAMPA, Fla. , June 2, 2025 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA"), a Phase 3 immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today announced that Moffitt Cancer Center presented a Trial in Progress poster of the Company's planned …

Amgen's Imdelltra reduced the risk of death by 40% compared to chemotherapy for small cell lung cancer patients whose disease had worsened after an initial round of chemo, according to interim data from a late-stage trial presented at a major medical meeting on Monday.

PAS-004 shows early signs of efficacy and strong tolerability in Phase 1 cancer trial, with tumor reductions and disease stability in pre-treated patients

NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE) (“Lineage” or the “Company”), the world's largest global temperature-controlled warehouse REIT, has issued a business update ahead of its fireside chat at Nareit's REITweek 2025 Investor Conference, scheduled for Tuesday, June 3, 2025, at 11:45 a.m. E.T. In the business update, which is available at ir.onelineage.com/events-and-presentations, Lineage is reaffirming its 2025 guidance and announcing that its second quarter to date is in l.

Three new cancer drugs could help AstraZeneca make a dent in its lofty ambition to become an $80 billion company by 2030.

Jeff Hirsch, Starz president and CEO, joins 'Squawk Box' to discuss the separation from Lionsgate, content spending, state of the media landscape, subscriber growth, and more.

Move aside Palantir Technologies. There's a new top stock in the S&P 500 so far this year — thanks to a stellar April.

The federal judge who will decide how to limit Google's monopoly in search is considering its advantages in artificial intelligence too, and aiming to limit harm to the other players in the market with any resolution.

In 2013, Stephen Curry shocked the sneaker world by signing with then-upstart apparel company Under Armour over basketball powerhouse Nike. The deal was considered a defining moment in Curry's business career.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infections, announces that the first patient has been dosed in the expansion arm of its Phase 1b/2 clinical trial evaluating Decoy20 in combination with BeOne's (formerly known as Beigene) PD-1 checkpoint inhibitor, tislelizumab. This newly activated arm of the trial will assess safety, dose optimization, and early signs of anti-tumor activity in patients with advanced solid tumors, previously treated with a checkpoint inhibitor or with tumors typically unresponsive to a checkpoint inhibitor.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Middle District of Florida on behalf of investors who purchased or acquired the securities of Treace Medical Concepts, Inc. ("Treace Medical" or the "Company") (NASDAQ: TMCI) between May 8, 2023 and May 7, 2024, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers (the "Complaint"). Should You Join This Class Action Lawsuit?

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Southern District of New York on behalf of investors (the "Class") who purchased or acquired the common stock of DoubleVerify Holdings, Inc. ("DoubleVerify" or the "Company") (NYSE: DV) between November 10, 2023 and February 27, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers. (the "Complaint").

BOCA RATON, FL / ACCESS Newswire / June 2, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today announced that the Company expects to list on the U.S. small-cap Russell 2000® Index, effective after the U.S. market opens on June 30, 2025, as part of the 2025 Russell indexes reconstitution. Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Southern District of New York on behalf of investors (the "Class") who purchased or acquired the securities of UnitedHealth Group Incorporated ("UnitedHealth" or the "Company") (NYSE: UNH) between December 3, 2024 and April 16, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers (the "Complaint"). Should You Join This Class Action Lawsuit?

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District of Oregon on behalf of investors (the "Class") who purchased or acquired the securities of Digimarc Corporation ("Digimarc" or the "Company") (NASDAQ: DMRC) between May 3, 2024 and February 26, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers (the "Complaint"). Should You Join This Class Action Lawsuit?

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Central District of California on behalf of investors (the "Class") who purchased or acquired the securities of Compass Group Diversified Holdings, LLC, and Compass Diversified Holdings ("Compass" or the "Company") (NYSE: CODI) between May 1, 2024 and May 7, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers (the "Complaint"). Should You Join …

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Eastern District of Virginia on behalf of investors who purchased or acquired the securities of MicroStrategy Incorporated d/b/a Strategy ("Strategy" or the "Company") (NASDAQ: MSTR) between April 30, 2024 and April 4, 2025, inclusive., alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers (the "Complaint").

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Middle District of North Carolina on behalf of investors who purchased or acquired the securities of NET Power Inc. ("Net Power" or the "Company") (NYSE: NPWR) between June 9, 2023 and March 7, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers (the "Complaint"). Should You Join This Class Action Lawsuit?

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Western District of Texas on behalf of investors (the "Class") who purchased or acquired the securities of Open Lending Corporation ("Open Lending" or the "Company") (NASDAQ: LPRO) between February 24, 2022 and March 31, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers (the "Complaint"). Should You Join This Class Action Lawsuit?